Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

J Hypertens

aDepartment of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece bPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique cDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium dDepartment of Medicine, Indiana University School of Medicine eRichard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA fService of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland gDepartment of Medicine, Maastricht University Medical Center, Maastricht hZuyderland Medical Center, Geleen, The Netherlands iDepartment of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK jService de Néphrologie-Immunologie Clinique, Hôpital Bretonneau, François-Rabelais University, Tours, France kSaarland University Medical Center; Internal Medicine IV - Nephrology and Hypertension, Homburg, Germany lDivision of Nephrology, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium mDepartment of Nephrology, Sfax University Hospital nResearch Unit, Faculty of Medicine, Sfax University, Sfax, Tunisia oDivision of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Turkey pCNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases Unit, Ospedali Riuniti, Reggio Calabria, Italy qInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK rIIS-Fundacion Jimenez Diaz, School of Medicine, University Autonoma of Madrid, FRIAT and REDINREN, Madrid, Spain sDepartment of Cardiovascular, Neural, and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan uUniversità degli Studi and IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova, Italy vINSERM, Centre d'Investigations Cliniques Plurithématique 1433, UMR 1116, Université de Lorraine, CHRU de Nancy wF-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, Nancy, France xHypertension Unit & Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain yDepartment of Nephrology and Hypertension, Universitair Ziekenhuis Brussel - VUB, Brussels zNephrology Section, Department of Internal Medicine, Ghent University Hospital, Gent, Belgium aaDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands bbDepartment of Nephrology, Transplantation and Internal Medicine Medical University of Silesia in Katowice, Katowice, Poland ccManhes Hospital and FCRIN INI-CRCTC, Manhes, France.

Published: April 2017

In patients with end-stage renal disease treated with hemodialysis or peritoneal dialysis, hypertension is very common and often poorly controlled. Blood pressure (BP) recordings obtained before or after hemodialysis display a J-shaped or U-shaped association with cardiovascular events and survival, but this most likely reflects the low accuracy of these measurements and the peculiar hemodynamic setting related with dialysis treatment. Elevated BP by home or ambulatory BP monitoring is clearly associated with shorter survival. Sodium and volume excess is the prominent mechanism of hypertension in dialysis patients, but other pathways, such as arterial stiffness, activation of the renin-angiotensin-aldosterone and sympathetic nervous systems, endothelial dysfunction, sleep apnea and the use of erythropoietin-stimulating agents may also be involved. Nonpharmacologic interventions targeting sodium and volume excess are fundamental for hypertension control in this population. If BP remains elevated after appropriate treatment of sodium-volume excess, the use of antihypertensive agents is necessary. Drug treatment in the dialysis population should take into consideration the patient's comorbidities and specific characteristics of each agent, such as dialysability. This document is an overview of the diagnosis, epidemiology, pathogenesis and treatment of hypertension in patients on dialysis, aiming to offer the renal physician practical recommendations based on current knowledge and expert opinion and to highlight areas for future research.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001283DOI Listing

Publication Analysis

Top Keywords

hypertension dialysis
8
dialysis patients
8
european renal
8
working group
8
group european
8
sodium volume
8
volume excess
8
hypertension
7
dialysis
6
patients
4

Similar Publications

Renal ischaemia due to renal artery stenosis produces two differing responses - a juxtaglomerular hypertensive response and cortical renal dysfunction. The reversibility of renal impairment is not predictable, and thus renal revascularisation is controversial. This study aims to test the hypothesis that the hypertensive response to renal ischaemia reflects viable renal parenchyma, and thus could be used to predict the recovery in renal function.

View Article and Find Full Text PDF

Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of end-stage kidney disease (ESKD) and occurs without racial predilection. In general, non-White ESKD patients have less access to transplantation, especially living donor transplantation. We examined long-term outcomes of ADPKD-ESKD patients by self-reported race, with attention to the trajectory of Estimated Post-Transplant Survival (EPTS) scores over time.

View Article and Find Full Text PDF

Aims: We aim to elucidate the association of baseline eGFR and incident heart failure on patients receiving intensive BP treatment.

Methods And Results: A post hoc analysis was conducted on the SPRINT database. Multivariab le Cox regression and interaction restricted cubic spline (RCS) analysis were performed to investigate the interaction between baseline eGFR and intensive BP control on heart failure prevention.

View Article and Find Full Text PDF

Background: We investigated factors associated with post-transplant growth in pediatric kidney transplant (KTx) recipients with a focus on plasma bicarbonate (HCO3) and estimated the effect of alkali treatment on growth.

Methods: In this study of the CERTAIN Registry, data were collected up to 5 years post-transplant. Generalized Additive Mixed Models were applied to assess the association between post-transplant growth and covariates.

View Article and Find Full Text PDF

Objective: Anemia is a common complication associated with adverse outcomes in older patients undergoing hemodialysis (HD). They also tend to experience malnutrition, which can affect the course of anemia. We hypothesized that the optimal hemoglobin (Hb) level varies depending on nutritional status in older patients undergoing HD and aimed to investigate the association between Hb levels and mortality according to nutritional status.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!